As Eli Lilly ends the year with Zepbound in good supply, TD Cowen analyst Steve Scaliaasked CEO David Ricks if the company ...

In a report released today, Jared Levine from TD Cowen maintained a Hold rating on Dayforce Inc (DAY – Research Report), with a price target of ...

TD Cowen analyst Bryan Bergin updated the financial outlook for Cognizant Technology Solutions (NASDAQ:CTSH), increasing the ...

TD Cowen analyst William Katz maintained a Hold rating on Franklin Resources (BEN – Research Report) today and set a price target of $20.00.

Seeing “growth on hiatus,” Mr. Bir reduced his own forecast for 2025 and 2026 “with revisions mainly for longer lease-up ...

Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared ...

Investing.com -- TD Cowen reinstated coverage on Tempus AI with a "Buy" rating and raised its price target to $74 after the health-tech company completed its $600 million acquisition of Ambry Genetics ...

Noting that Ambry is a profitable testing laboratory that generates more than $300 million of revenue annually, the investment bank thinks that the deal will enable TEM to start generating positive ...

Fintel reports that on February 5, 2025, TD Cowen initiated coverage of Palvella Therapeutics (NasdaqCM:PVLA) with a Buy ...

OSI Systems, Inc. (NASDAQ: OSIS), today announced that it will present at the TD Cowen 46th Annual Aerospace & Defense Conference on Wednesday, February 12, 2025, at 10:45 AM ET.